Primary Progressive Multiple Sclerosis

Goal: Developed from the MURDOCK Multiple Sclerosis Study, this study  seeks to understand the development and progression of the primary progressive sub-type of MS, which is characterized by a continuous display of symptoms, rather than periods of relapse and remission.  Approximately 10% of MS patients are afflicted by primary progressive MS, yet no treatment has proven successful for this sub-type.


Principal Investigator: Dr. Simon Gregory


MURDOCK study and more